These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31960628)

  • 1. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement.
    Fine JM; Kosyakovsky J; Baillargeon AM; Tokarev JV; Cooner JM; Svitak AL; Faltesek KA; Frey WH; Hanson LR
    Brain Behav; 2020 Mar; 10(3):e01536. PubMed ID: 31960628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.
    Fine JM; Baillargeon AM; Renner DB; Hoerster NS; Tokarev J; Colton S; Pelleg A; Andrews A; Sparley KA; Krogh KM; Frey WH; Hanson LR
    Exp Brain Res; 2012 Jun; 219(3):381-90. PubMed ID: 22547371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
    Farr AC; Xiong MP
    Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation.
    Fine JM; Renner DB; Forsberg AC; Cameron RA; Galick BT; Le C; Conway PM; Stroebel BM; Frey WH; Hanson LR
    Neurosci Lett; 2015 Jan; 584():362-7. PubMed ID: 25445365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease.
    Fine JM; Forsberg AC; Stroebel BM; Faltesek KA; Verden DR; Hamel KA; Raney EB; Crow JM; Haase LR; Knutzen KE; Kaczmarczek KD; Frey WH; Hanson LR
    J Neurol Sci; 2017 Sep; 380():164-171. PubMed ID: 28870559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry.
    Kosyakovsky J; Witthuhn BA; Svitak AL; Frey WH; Hanson LR; Fine JM
    ACS Chem Neurosci; 2019 Nov; 10(11):4571-4578. PubMed ID: 31573798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.
    Hanson LR; Fine JM; Renner DB; Svitak AL; Burns RB; Nguyen TM; Tuttle NJ; Marti DL; Panter SS; Frey WH
    Drug Deliv Transl Res; 2012 Jun; 2(3):160-8. PubMed ID: 25786865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.
    Zhang XY; Cao JB; Zhang LM; Li YF; Mi WD
    J Neuroinflammation; 2015 Feb; 12():20. PubMed ID: 25644393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
    Hou Z; Nie C; Si Z; Ma Y
    Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
    Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
    J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine preconditioning activated hypoxia-inducible factor-1α and MyD88-dependent Toll-like receptor 4 signaling in intestinal stem cells.
    Chen Y; Yang XQ; Tseng BY; Tsai YH; Tseng SH; Lee CH; Yao CL
    J Pediatr Surg; 2018 Nov; 53(11):2349-2356. PubMed ID: 29475626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.
    Fine JM; Forsberg AC; Renner DB; Faltesek KA; Mohan KG; Wong JC; Arneson LC; Crow JM; Frey WH; Hanson LR
    Brain Res; 2014 Jul; 1574():96-104. PubMed ID: 24928620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds.
    Duscher D; Trotsyuk AA; Maan ZN; Kwon SH; Rodrigues M; Engel K; Stern-Buchbinder ZA; Bonham CA; Barrera J; Whittam AJ; Hu MS; Inayathullah M; Rajadas J; Gurtner GC
    J Control Release; 2019 Aug; 308():232-239. PubMed ID: 31299261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice.
    You L; Wang J; Liu T; Zhang Y; Han X; Wang T; Guo S; Dong T; Xu J; Anderson GJ; Liu Q; Chang YZ; Lou X; Nie G
    ACS Nano; 2018 May; 12(5):4123-4139. PubMed ID: 29617109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice.
    Bonham CA; Rodrigues M; Galvez M; Trotsyuk A; Stern-Buchbinder Z; Inayathullah M; Rajadas J; Gurtner GC
    Wound Repair Regen; 2018 May; 26(3):300-305. PubMed ID: 30152571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
    Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
    Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.
    Liu Y; Cui Y; Shi M; Zhang Q; Wang Q; Chen X
    Cell Physiol Biochem; 2014; 33(4):1036-46. PubMed ID: 24732598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
    Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
    J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.